<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-04-08T09:21:45Z</responseDate>
  <request identifier="oai:pub.unibl.org:24170" metadataPrefix="oai_dcterms" verb="GetRecord">https://pub.unibl.org/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pub.unibl.org:24170</identifier>
        <datestamp>2025-10-01T04:47:53Z</datestamp>
      </header>
      <metadata>
        <oai_dcterms:dcterms xmlns:oai_dcterms="http://www.openarchives.org/OAI/2.0/oai_dcterms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dcterms/ http://www.openarchives.org/OAI/2.0/oai_dcterms.xsd">
          <dcterms:title>Menopausal Status, HER-2 Status, Status of Steroid Receptor, Lymph Nodes Metastases Status and Resistance to Tamoxifen- Our Clinical Study</dcterms:title>
          <dcterms:creator xsi:type="dcterms:URI" title="Синиша Максимовић">/unibl/author/Siniša Maksimović</dcterms:creator>
          <dcterms:date>2019-10</dcterms:date>
          <dcterms:type>Conference Paper</dcterms:type>
          <dcterms:type>text</dcterms:type>
          <dcterms:format>20</dcterms:format>
          <dcterms:format>1</dcterms:format>
          <dcterms:identifier>/unibl/sci/idNaucniRad:24251</dcterms:identifier>
          <dcterms:relation xsi:type="dcterms:URI" title="Медицински факултет">https://med.unibl.org</dcterms:relation>
          <dcterms:relation>39th Congress of the European Society of Surgical Oncology</dcterms:relation>
          <dcterms:relation>Final Programme, 39th Congress of the European Society of Surgical Oncology, Rotterdam, The Netherlands, 9 – 11 October 2019.</dcterms:relation>
          <dcterms:isPartOf>Final Programme, 39th Congress of the European Society of Surgical Oncology, Rotterdam, The Netherlands, 9 – 11 October 2019.</dcterms:isPartOf>
          <dcterms:references xsi:type="dcterms:URI">http://esso39.org/programme.htm</dcterms:references>
          <dcterms:bibliographicCitation>S. Maksimović, Menopausal Status, HER-2 Status, Status of Steroid Receptor, Lymph Nodes Metastases Status and Resistance to Tamoxifen- Our Clinical Study, Final Programme, 39th Congress of the European Society of Surgical Oncology, Rotterdam, The Netherlands, 9 – 11 October 2019., pp. 1 - 20, Oct, 2019</dcterms:bibliographicCitation>
          <dcterms:identifier xsi:type="dcterms:URI">https://pub.unibl.org/s/cir/item/24170</dcterms:identifier>
        </oai_dcterms:dcterms>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>